RAD51C p.Gly149Glu
Variant summary
The NM_058216.3(RAD51C):c.446G>A (p.Gly149Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a cumulative frequency of 0.000000684 (AC=1) in the gnomAD database across 1,461,878 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.000000899. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 8.84). Variant has been reported in ClinVar as Uncertain Significance (★★). Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.G149= (synonymous): Benign (ClinVar VariationId 3903704, 1 star); p.G149= (synonymous): Likely_benign (ClinVar VariationId 1740875, 2 stars)
Frequency
Consequence
NM_058216.3 missense
Scores
Clinical Significance
Conservation
Publications
- RAD51C-related cancer predispositionInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- breast-ovarian cancer, familial, susceptibility to, 3Inheritance: AD Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
- Fanconi anemia complementation group OInheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia
- hereditary breast ovarian cancer syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Fanconi anemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
Classification according to ACMG Germline Pathogenicity v2019
Our verdict: Uncertain_significance. The variant received 4 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| PM1Mutational hot spot or critical domain | Missense neighbourhood moderate hotspot (≥2 P/LP within ±8 AA, OR ≥ 2 vs. background) — PM1 supporting; In-domain: 0 pathogenic, 0 benign rare missense variants.; ±8 AA neighbourhood: 5 pathogenic, 9 benign (OR vs. background: 2.9). | ||
| PM2Absent/extremely low in population databases | Very rare in gnomAD for AD/XL gene (popmax AF < threshold/10) — PM2; GnomAD popmax AF = 0.000000899 — very rare for AD+AR gene (threshold 0.0001) — PM2 moderate. | ||
| PP3Computational evidence supports damaging effect | Germline meta computational scorer (REVEL/MetaRNN/BayesDel) predicts damaging effect — supporting evidence (PP3); Splicing verdict: not pathogenic.; Germline computational verdict: pathogenic (Supporting). |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_058216.3. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
RAD51C | TSL:1MANE Select | c.446G>A p.Gly149Glu | missense | Exon 3 of 9 | Prot: ENSP00000336701.4 UniProt: | |
RAD51C | TSL:1 | n.404+1545G>A | intron | Intron 2 of 7 | Prot: ENSP00000433332.1 UniProt: | |
RAD51C | c.446G>A p.Gly149Glu | missense | Exon 3 of 10 | Prot: ENSP00000600482.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 3 sources | |||||
GnomAD3 genomes | Cov:32 | ||||
GnomAD4 exome | AF: 6.84e-7 | AC:1 | Hom:0 | AN:1461878 | Cov:31 |
GnomAD4 genome | Cov:32 | ||||
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
SCHEMA | 0.0000290 | 3 | 103334 | 0.0000271 | 5 | 184568 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 29 | |
AlphaMissense | Pathogenic | 0.76 | |
BayesDel_addAF | Pathogenic | 0.28 | D |
BayesDel_noAF | Pathogenic | 0.16 | |
CADD | Pathogenic | 30 | |
DANN | Uncertain | 1.0 | |
DEOGEN2 | Benign | 0.11 | T |
Eigen | Pathogenic | 0.73 | |
Eigen_PC | Pathogenic | 0.75 | |
FATHMM_MKL | Uncertain | 0.94 | D |
FuncVEP CTI | Pathogenic | 0.46 | |
GPN-Star LLR | N/A | -7.4 | |
GPN-Star score | N/A | 7.4 | |
LIST_S2 | Uncertain | 0.94 | D |
M_CAP | Benign | 0.049 | D |
MetaRNN | Pathogenic | 0.88 | D |
MetaSVM | Uncertain | 0.44 | D |
Mutation Taster | N/A | 6/94 | disease causing |
MutationAssessor | Pathogenic | 3.3 | M |
PhyloP100 | Pathogenic | 8.8 | |
popEVE | Benign | -3.5 | |
PrimateAI | Uncertain | 0.68 | T |
PROVEAN | Pathogenic | -7.3 | D |
REVEL | Pathogenic | 0.69 | |
Sift | Uncertain | 0.0010 | D |
Sift4G | Uncertain | 0.0030 | D |
Varity_R | N/A | 0.93 | |
VESM-3B | Benign | -11 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.